GlassScriptPhysician profile
Robert D Pintauro
NPI 1942393343
$34,537.11
in general payments reported to CMS, 2019-2025
69 companies · $3,974 in 2025
The $3,974 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,344 · 2020: $3,053 · 2021: $6,737 · 2022: $5,688 · 2023: $5,276 · 2024: $4,465 · 2025: $3,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,520.19 |
| Education | $195.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $4,961.74 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $3,277.42 | 2019-2025 | Farxiga, Fasenra, Airsupra |
| Amgen INC. | $2,656.40 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbvie INC. | $2,194.57 | 2021-2025 | |
| Lilly USA, LLC | $1,560.09 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $1,452.39 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Sanofi-Aventis U.S. LLC | $1,442.26 | 2019-2024 | |
| Glaxosmithkline, LLC. | $1,402.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Genzyme Corporation | $1,164.79 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $952.44 | 2023-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $895.17 | 2019-2024 | Stiolto Respimat, Spiriva Respimat, Cyltezo |
| Esperion Therapeutics, INC. | $795.02 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $792.00 | 2021-2025 | |
| Boston Scientific Corporation | $791.69 | 2019-2025 | General - Therapies |
| Novartis Pharmaceuticals Corporation | $736.64 | 2019-2025 |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $725.28 | 2019-2025 | |
| Allergan, INC. | $703.82 | 2019-2020 | |
| Astellas Pharma US INC | $630.51 | 2019-2025 | Veozah, Myrbetriq |
| Lundbeck LLC | $562.65 | 2019-2025 | Rexulti, Abilify Maintena |
| Biohaven Pharmaceuticals, INC. | $471.98 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $377.31 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Janssen Pharmaceuticals, INC | $325.96 | 2019-2023 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $319.00 | 2022 | |
| Ucb, INC. | $297.36 | 2023-2024 | Nayzilam, Briviact |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.79 | 2020-2024 | Cycloset |
| Abbott Laboratories | $282.73 | 2019-2024 | Freestyle Libre 3 |
| Ardelyx, INC. | $271.00 | 2024-2025 | Ibsrela |
| Amarin Pharma, INC. | $257.97 | 2019-2023 | |
| Recor Medical INC | $245.90 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cagent Vascular INC | $222.99 | 2023-2024 | Serrantor |
| E.R. Squibb & Sons, L.L.C. | $222.97 | 2019-2023 | Eliquis |
| Exact Sciences Corporation | $209.62 | 2023-2025 | Cologuard Collection Kit |
| Intra-Sana Laboratories | $205.59 | 2023-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Gilead Sciences, INC. | $202.33 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $200.39 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $198.21 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $185.48 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $178.45 | 2022-2025 | Contrave, Onzetra Xsail, Nexlizet |
| Takeda Pharmaceuticals U.S.A., INC. | $176.80 | 2020-2024 | Trintellix |
| Neurocrine Biosciences, INC. | $162.17 | 2023 | Ingrezza |
| Stryker Corporation | $130.78 | 2024 | Dart-Fire, Easyfuse |
| Medtronic Minimed, INC. | $125.34 | 2020 | |
| Medtronic USA, INC. | $124.99 | 2019 | |
| Vanda Pharmaceuticals INC. | $102.68 | 2024-2025 | Fanapt, Hetlioz |
| Ibsa Pharma INC. | $96.40 | 2023-2024 | Tirosint, Licart, Tirosint |
| Aimmune Therapeutics, INC. | $93.11 | 2024-2025 | Zenpep |
| Vbi Vaccine (Delaware) INC. | $76.93 | 2022-2023 | Prehevbrio |
| Arbor Pharmaceuticals, INC. | $75.84 | 2019-2021 | |
| Becton, Dickinson and Company | $71.41 | 2022 | |
| Acorda Therapeutics, INC | $60.56 | 2019 | |
| Paratek Pharmaceuticals, INC. | $56.72 | 2024-2025 | Nuzyra |
| Eisai INC. | $50.40 | 2021-2022 | |
| Dexcom, INC. | $47.68 | 2024-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $45.86 | 2024 | Voquezna |
| Sumitomo Pharma America, INC. | $44.93 | 2024-2025 | Gemtesa |
| Horizon Therapeutics Plc | $44.13 | 2021 | |
| Mannkind Corporation | $41.65 | 2019-2020 | |
| Bardy Diagnostics, INC. | $34.00 | 2020 | |
| Xeris Pharmaceuticals, INC. | $24.99 | 2025 | Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $23.87 | 2025 | Dupixent |
| Cumberland Pharmaceuticals, INC. | $22.94 | 2025 | Kristalose |
| Embecta Corp. | $22.34 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Azurity Pharmaceuticals, INC. | $22.02 | 2025 | Edarbi |
| Sunovion Pharmaceuticals INC. | $21.59 | 2021 | |
| Nestle Healthcare Nutrition INC. | $21.34 | 2023 | |
| Genentech USA, INC. | $18.19 | 2019 | |
| Hikma Pharmaceuticals USA | $15.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.20 | 2020 | |
| G Medical Diagnostic Services, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
Dupixent $999Caplyta $952Rexulti $757Ozempic $701Farxiga $631Otezla $562Abilify Maintena $537Vraylar $496Fasenra $486Wegovy $471Repatha $466Nexletol $394Rybelsus $369Trelegy Ellipta $350Airsupra $337Mounjaro $325Verquvo $316Nayzilam $275Evenity $274Ibsrela $271Ubrelvy $267Abilify Asimtufii $260Leqvio $257Lokelma $248Paradise Ultrasound Renal Denervation System $246Serrantor $223Cologuard Collection Kit $210Glycate $206Reltone 200 Mg $206Reltone 400 Mg $206Prolia $197Zepbound $184Entresto $181Jardiance $181Nurtec Odt $177Ingrezza $162Breztri $158Arexvy $156Eliquis $150Tirosint $145Kerendia $131Dart-Fire $131Easyfuse $131Comirnaty $129Zavzpret $125Veozah $118Zenpep $114Qulipta $110Contrave $109Abrysvo $105Prevnar 20 $105Fanapt $103General - Therapies $101Stiolto Respimat $100Trintellix $98.32Licart $96.40Shingrix $85.32Onzetra Xsail $80.05Emgality $78.42Cycloset $71.25Spiriva Respimat $69.55Soliqua 100/33 $60.99Kisunla $60.12Nuzyra $56.72Cyltezo $56.52Paxlovid $51.55Reyvow $49.17Dexcom G6 Transmitter $47.68Voquezna $45.86Gemtesa $44.93Vascepa $44.53Freestyle Libre 3 $41.07Steglatro $40.48Belsomra $40.48Hetlioz $37.20Krystexxa $35.54Prehevbrio $31.68Tradjenta $28.62Synjardy $28.62Toujeo $26.35Vyndaqel $26.00Gvoke Hypopen $24.99Xarelto $24.59Saxenda $24.56Kristalose $22.94Myrbetriq $22.50Bd Nano 2nd Gen Pen Needle $22.34Briviact $22.29Edarbi $22.02Nuedexta $21.53Capvaxive $19.61Nexlizet $17.11
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pintauro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.